Thiazolidinedione Activation of Peroxisome Proliferator-activated Receptor γ Can Enhance Mitochondrial Potential and Promote Cell Survival

Thiazolidinedione Peroxisome proliferator
DOI: 10.1074/jbc.m204279200 Publication Date: 2002-08-26T14:39:46Z
ABSTRACT
Thiazolidinediones (TZDs) are widely used for treatment of type 2 diabetes mellitus. Peroxisome proliferator-activated receptor gamma (PPAR gamma) is the molecular target TZDs and believed to mediate apoptotic effects this class drugs in a variety cell types, including B T lymphocytes. The finding that induce lymphocyte death has raised concerns regarding whether might further impair immune functions diabetics. To address issue, we investigated roles PPAR survival. was up-regulated upon activation. As previously reported, agonists induced dose-dependent manner. However, concentrations TZD needed cause were above those gamma-dependent transcription. Surprisingly, at optimal transcriptional activation, activation protected cells from apoptosis following growth factor withdrawal. survival-enhancing depended on both presence gamma. Measurements mitochondrial potential revealed enhanced ability maintain their potential. These data indicate with can promote survival suggest may potentially augment responses diabetic patients.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (43)
CITATIONS (100)